Literature DB >> 21512964

Subclinical hypothyroidism and the prevalence of the metabolic syndrome.

C Liu1, W A Scherbaum, M Schott, S Schinner.   

Abstract

There is currently controversial data regarding the prevalence of MS among SCH patients. The aim of the study was to investigate the prevalence of MS in an adult population with SCH. A cross-sectional study was conducted among 6,998 adults in China. Epidemiological information and medical data were obtained (fasting plasma glucose, triglycerides, high density lipoprotein-C, and thyroid function). The IDF criteria were applied for the diagnosis of MS. SCH was defined as TSH more than 4.5 mIU/l with normal values for FT3 and FT4. Among the 6,560 participants, 21.5% were diagnosed with MS and 8.2% suffered from SCH. MS was found in 21.3% in the euthyroidism (EUT) group and in 25.7% in the SCH group (p<0.05). However, this difference between EUT and SCH in MS prevalence was not statistically significant after adjusting for age. Of note, the prevalence of MS increased with age. The proportions of systemic hypertension, hypertriglyceridemia, impaired fasting glucose, and low HDL-C were 86.7, 59.7, 45.1 and 65.9% in EUT while the corresponding values in SCH were 89.9, 63.8, 39.9 and 72.5%, respectively (the differences, however, did not reach statistical significance). The prevalence of high BP, high TG, elevated FBP, and low HDL-C as well as the percentage of patients fulfilling the IDF criteria for the metabolic syndrome are not significantly different among SCH and EUT after adjusting for age. Therefore, subclinical hypothyroidism appears not as an independent risk factor for the metabolic syndrome in this population. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21512964     DOI: 10.1055/s-0031-1275719

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.

Authors:  Ulla Ludwig; Daniela Holzner; Christian Denzer; Artur Greinert; Mark Martin Haenle; Suemeyra Oeztuerk; Wolfgang Koenig; Bernhard Otto Boehm; Richard Andrew Mason; Wolfgang Kratzer; Tilmann Graeter
Journal:  BMC Endocr Disord       Date:  2015-08-15       Impact factor: 2.763

2.  Secondary metabolic syndrome: the frequency of factors which may underlie the parameters of metabolic syndrome.

Authors:  Aytekin Oguz; Banu Mesci; Gul Sagun; Damla Coksert Kilic; Demet Ozgil Yetkin; Arzu Akalin
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

3.  The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population.

Authors:  Meng Li; Xiuying Zhang; Xianghai Zhou; Xueyao Han; Rui Zhang; Zuodi Fu; Lianying Wang; Ying Gao; Yufeng Li; Linong Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-16       Impact factor: 3.168

4.  Sex differences in subclinical hypothyroidism and associations with metabolic risk factors: a health examination-based study in mainland China.

Authors:  Li Jiang; Jinman Du; Weizhu Wu; Jianjiang Fang; Jufang Wang; Jinhua Ding
Journal:  BMC Endocr Disord       Date:  2020-07-06       Impact factor: 2.763

Review 5.  The role of thyroid hormone in metabolism and metabolic syndrome.

Authors:  Patrícia de Fátima Dos Santos Teixeira; Patrícia Borges Dos Santos; Carmen Cabanelas Pazos-Moura
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-13       Impact factor: 3.565

6.  The Positive Association between Subclinical Hypothyroidism and Newly-Diagnosed Hypertension Is More Explicit in Female Individuals Younger than 65.

Authors:  Xichang Wang; Haoyu Wang; Li Yan; Lihui Yang; Yuanming Xue; Jing Yang; Yongli Yao; Xulei Tang; Nanwei Tong; Guixia Wang; Jinan Zhang; Youmin Wang; Jianming Ba; Bing Chen; Jianling Du; Lanjie He; Xiaoyang Lai; Yanbo Li; Zhaoli Yan; Eryuan Liao; Chao Liu; Libin Liu; Guijun Qin; Yingfen Qin; Huibiao Quan; Bingyin Shi; Hui Sun; Zhen Ye; Qiao Zhang; Lihui Zhang; Jun Zhu; Mei Zhu; Yongze Li; Weiping Teng; Zhongyan Shan
Journal:  Endocrinol Metab (Seoul)       Date:  2021-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.